A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
Philip
George
G
Merck Research Laboratories, North Wales, PA 19454, USA. george_philip@merck.com
Pedinoff
Andrew
A
Vandormael
Kristel
K
Tymofyeyev
Yevgen
Y
Smugar
Steven S
SS
Reiss
Theodore F
TF
Korenblat
Phillip E
PE